Rank | Gene Set | Z-score |
---|---|---|
1 | nuclear pore complex assembly (GO:0051292) | 5.45005754 |
2 | formation of translation preinitiation complex (GO:0001731) | 4.84192397 |
3 | nuclear pore organization (GO:0006999) | 4.71266780 |
4 | regulation of translational fidelity (GO:0006450) | 4.51086914 |
5 | ribosomal small subunit biogenesis (GO:0042274) | 4.32109057 |
6 | DNA replication initiation (GO:0006270) | 4.25878621 |
7 | mitotic chromosome condensation (GO:0007076) | 4.24584323 |
8 | L-phenylalanine metabolic process (GO:0006558) | 4.21140242 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.21140242 |
10 | glycine metabolic process (GO:0006544) | 4.14173270 |
11 | pore complex assembly (GO:0046931) | 4.13942088 |
12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.13065991 |
13 | L-phenylalanine catabolic process (GO:0006559) | 4.13065991 |
14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.08360838 |
15 | maturation of SSU-rRNA (GO:0030490) | 3.97734478 |
16 | proline biosynthetic process (GO:0006561) | 3.89926413 |
17 | serine family amino acid biosynthetic process (GO:0009070) | 3.86379925 |
18 | aromatic amino acid family catabolic process (GO:0009074) | 3.85647889 |
19 | cysteine metabolic process (GO:0006534) | 3.83003717 |
20 | telomere maintenance via recombination (GO:0000722) | 3.81640671 |
21 | urea cycle (GO:0000050) | 3.80457815 |
22 | urea metabolic process (GO:0019627) | 3.80457815 |
23 | alpha-linolenic acid metabolic process (GO:0036109) | 3.77153746 |
24 | Golgi transport vesicle coating (GO:0048200) | 3.73178314 |
25 | COPI coating of Golgi vesicle (GO:0048205) | 3.73178314 |
26 | glyoxylate metabolic process (GO:0046487) | 3.72364855 |
27 | mitotic sister chromatid segregation (GO:0000070) | 3.71555025 |
28 | mitotic nuclear envelope disassembly (GO:0007077) | 3.70226309 |
29 | ribosomal large subunit biogenesis (GO:0042273) | 3.68945586 |
30 | sulfur amino acid catabolic process (GO:0000098) | 3.67359958 |
31 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.61253389 |
32 | serine family amino acid catabolic process (GO:0009071) | 3.59958674 |
33 | serine family amino acid metabolic process (GO:0009069) | 3.59439304 |
34 | tryptophan catabolic process (GO:0006569) | 3.59370263 |
35 | indole-containing compound catabolic process (GO:0042436) | 3.59370263 |
36 | indolalkylamine catabolic process (GO:0046218) | 3.59370263 |
37 | ribosome assembly (GO:0042255) | 3.58510725 |
38 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.55612592 |
39 | kynurenine metabolic process (GO:0070189) | 3.55484161 |
40 | mitotic recombination (GO:0006312) | 3.52992522 |
41 | nitrogen cycle metabolic process (GO:0071941) | 3.52498048 |
42 | DNA topological change (GO:0006265) | 3.48011813 |
43 | sister chromatid segregation (GO:0000819) | 3.47454247 |
44 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.46153236 |
45 | establishment of integrated proviral latency (GO:0075713) | 3.45598015 |
46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44430236 |
47 | viral transcription (GO:0019083) | 3.42937304 |
48 | membrane disassembly (GO:0030397) | 3.42201969 |
49 | nuclear envelope disassembly (GO:0051081) | 3.42201969 |
50 | amino-acid betaine metabolic process (GO:0006577) | 3.41874411 |
51 | tryptophan metabolic process (GO:0006568) | 3.37735385 |
52 | ribosome biogenesis (GO:0042254) | 3.34264540 |
53 | translational termination (GO:0006415) | 3.32682400 |
54 | lysine catabolic process (GO:0006554) | 3.32331000 |
55 | lysine metabolic process (GO:0006553) | 3.32331000 |
56 | regulation of triglyceride catabolic process (GO:0010896) | 3.30593173 |
57 | tetrahydrofolate metabolic process (GO:0046653) | 3.27036843 |
58 | valine metabolic process (GO:0006573) | 3.26595876 |
59 | bile acid biosynthetic process (GO:0006699) | 3.26125572 |
60 | L-serine metabolic process (GO:0006563) | 3.25663992 |
61 | folic acid metabolic process (GO:0046655) | 3.24335648 |
62 | protein localization to chromosome, centromeric region (GO:0071459) | 3.24261691 |
63 | triglyceride homeostasis (GO:0070328) | 3.19478358 |
64 | acylglycerol homeostasis (GO:0055090) | 3.19478358 |
65 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.17785778 |
66 | homocysteine metabolic process (GO:0050667) | 3.16944960 |
67 | negative regulation of fibrinolysis (GO:0051918) | 3.16673095 |
68 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.15361270 |
69 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.15361270 |
70 | imidazole-containing compound metabolic process (GO:0052803) | 3.15202803 |
71 | tRNA aminoacylation for protein translation (GO:0006418) | 3.14371303 |
72 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14322537 |
73 | high-density lipoprotein particle remodeling (GO:0034375) | 3.13867880 |
74 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.12264403 |
75 | DNA replication checkpoint (GO:0000076) | 3.12162324 |
76 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.11663684 |
77 | translational initiation (GO:0006413) | 3.10465160 |
78 | viral mRNA export from host cell nucleus (GO:0046784) | 3.08431947 |
79 | regulation of mitochondrial translation (GO:0070129) | 3.07866799 |
80 | complement activation, alternative pathway (GO:0006957) | 3.07637800 |
81 | DNA duplex unwinding (GO:0032508) | 3.04913577 |
82 | negative regulation of sterol transport (GO:0032372) | 3.04645450 |
83 | negative regulation of cholesterol transport (GO:0032375) | 3.04645450 |
84 | amino acid activation (GO:0043038) | 3.04249170 |
85 | tRNA aminoacylation (GO:0043039) | 3.04249170 |
86 | protein maturation by protein folding (GO:0022417) | 3.02708665 |
87 | protein targeting to ER (GO:0045047) | 3.02433494 |
88 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.02399679 |
89 | cotranslational protein targeting to membrane (GO:0006613) | 3.02296181 |
90 | one-carbon metabolic process (GO:0006730) | 3.02190955 |
91 | translational elongation (GO:0006414) | 3.01197015 |
92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.99409408 |
93 | protein carboxylation (GO:0018214) | 2.99409408 |
94 | regulation of protein activation cascade (GO:2000257) | 2.99155908 |
95 | plasma lipoprotein particle clearance (GO:0034381) | 2.96109623 |
96 | regulation of translational termination (GO:0006449) | 2.95172167 |
97 | IMP metabolic process (GO:0046040) | 2.94794758 |
98 | protein localization to kinetochore (GO:0034501) | 2.94577858 |
99 | plasma lipoprotein particle remodeling (GO:0034369) | 2.94077076 |
100 | protein-lipid complex remodeling (GO:0034368) | 2.94077076 |
101 | macromolecular complex remodeling (GO:0034367) | 2.94077076 |
102 | negative regulation of mRNA processing (GO:0050686) | 2.93446993 |
103 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.92760229 |
104 | alpha-amino acid catabolic process (GO:1901606) | 2.91918384 |
105 | nucleobase biosynthetic process (GO:0046112) | 2.91810429 |
106 | aldehyde catabolic process (GO:0046185) | 2.91477053 |
107 | telomere maintenance via telomere lengthening (GO:0010833) | 2.91203029 |
108 | DNA geometric change (GO:0032392) | 2.90143122 |
109 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.89870761 |
110 | aromatic amino acid family metabolic process (GO:0009072) | 2.89013407 |
111 | carnitine metabolic process (GO:0009437) | 2.88761349 |
112 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.87163590 |
113 | regulation of cholesterol esterification (GO:0010872) | 2.86836119 |
114 | * nucleobase-containing small molecule interconversion (GO:0015949) | 2.86791458 |
115 | negative regulation of RNA splicing (GO:0033119) | 2.86626862 |
116 | protein localization to endoplasmic reticulum (GO:0070972) | 2.85148954 |
117 | bile acid metabolic process (GO:0008206) | 2.84763908 |
118 | folic acid-containing compound metabolic process (GO:0006760) | 2.83962162 |
119 | regulation of mitotic spindle organization (GO:0060236) | 2.83226647 |
120 | regulation of cholesterol homeostasis (GO:2000188) | 2.82626703 |
121 | regulation of fibrinolysis (GO:0051917) | 2.82562879 |
122 | DNA conformation change (GO:0071103) | 2.82083397 |
123 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.81893492 |
124 | regulation of complement activation (GO:0030449) | 2.81688102 |
125 | ribosomal small subunit assembly (GO:0000028) | 2.80185175 |
126 | purine nucleobase biosynthetic process (GO:0009113) | 2.79950571 |
127 | viral life cycle (GO:0019058) | 2.79135484 |
128 | ethanol oxidation (GO:0006069) | 2.78247004 |
129 | DNA strand elongation (GO:0022616) | 2.76165287 |
130 | mitotic metaphase plate congression (GO:0007080) | 2.75817086 |
131 | nuclear envelope organization (GO:0006998) | 2.75717291 |
132 | chromosome condensation (GO:0030261) | 2.75242074 |
133 | regulation of translational elongation (GO:0006448) | 2.75131337 |
134 | rRNA processing (GO:0006364) | 2.74037578 |
135 | low-density lipoprotein particle clearance (GO:0034383) | 2.72459209 |
136 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.71276398 |
137 | DNA deamination (GO:0045006) | 2.71240565 |
138 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.70852790 |
139 | negative regulation of mRNA metabolic process (GO:1903312) | 2.69735278 |
140 | fatty acid beta-oxidation (GO:0006635) | 2.69714506 |
141 | cellular amino acid catabolic process (GO:0009063) | 2.69171669 |
142 | establishment of viral latency (GO:0019043) | 2.69162928 |
143 | NADH metabolic process (GO:0006734) | 2.68409870 |
144 | cellular protein complex disassembly (GO:0043624) | 2.68385229 |
145 | phospholipid efflux (GO:0033700) | 2.68338027 |
146 | plasma lipoprotein particle assembly (GO:0034377) | 2.65557967 |
147 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.65093665 |
148 | regulation of RNA export from nucleus (GO:0046831) | 2.64245313 |
149 | mitotic sister chromatid cohesion (GO:0007064) | 2.64196663 |
150 | pentose-phosphate shunt (GO:0006098) | 2.63869676 |
151 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.63822654 |
152 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.63092358 |
153 | DNA unwinding involved in DNA replication (GO:0006268) | 2.62865081 |
154 | reverse cholesterol transport (GO:0043691) | 2.62646831 |
155 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.62442674 |
156 | bile acid and bile salt transport (GO:0015721) | 2.62309440 |
157 | cholesterol homeostasis (GO:0042632) | 2.61522260 |
158 | rRNA metabolic process (GO:0016072) | 2.60641651 |
159 | nucleoside salvage (GO:0043174) | 2.60051711 |
160 | dosage compensation (GO:0007549) | 2.59983047 |
161 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.59830760 |
162 | oxaloacetate metabolic process (GO:0006107) | 2.59741049 |
163 | translation (GO:0006412) | 2.58941149 |
164 | proline metabolic process (GO:0006560) | 2.57839036 |
165 | fatty acid oxidation (GO:0019395) | 2.57163754 |
166 | sterol homeostasis (GO:0055092) | 2.56921484 |
167 | DNA ligation (GO:0006266) | 2.56576274 |
168 | pteridine-containing compound metabolic process (GO:0042558) | 2.55702268 |
169 | protein complex disassembly (GO:0043241) | 2.55670117 |
170 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.55307066 |
171 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.55307066 |
172 | tyrosine metabolic process (GO:0006570) | 2.55191151 |
173 | cellular component biogenesis (GO:0044085) | 2.54921170 |
174 | protein export from nucleus (GO:0006611) | 2.54501786 |
175 | IMP biosynthetic process (GO:0006188) | 2.54450999 |
176 | acetyl-CoA metabolic process (GO:0006084) | 2.54366225 |
177 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.53771974 |
178 | primary alcohol catabolic process (GO:0034310) | 2.53119860 |
179 | 2-oxoglutarate metabolic process (GO:0006103) | 2.53045824 |
180 | pinocytosis (GO:0006907) | 2.52842323 |
181 | cellular glucuronidation (GO:0052695) | 2.52827912 |
182 | NADPH regeneration (GO:0006740) | 2.52790904 |
183 | regulation of cholesterol storage (GO:0010885) | 2.51895083 |
184 | response to nitrosative stress (GO:0051409) | 2.51675395 |
185 | non-recombinational repair (GO:0000726) | 2.51380022 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.39877258 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.02561150 |
3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.69717208 |
4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.37353390 |
5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.28189163 |
6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.18589852 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.10206095 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90629034 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.75272809 |
10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.40237475 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.34864869 |
12 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.34385888 |
13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.27742745 |
14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.19761818 |
15 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.14211822 |
16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.01263794 |
17 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.98366845 |
18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.96126940 |
19 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.89943785 |
20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89663925 |
21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.89313749 |
22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.87586565 |
23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.80660175 |
24 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77755378 |
25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76724781 |
26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74675256 |
27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.72157521 |
28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.71146807 |
29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.68835116 |
30 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.68039255 |
31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.63759019 |
32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.63489553 |
33 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.62091265 |
34 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57881556 |
35 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55591262 |
36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52624366 |
37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52604799 |
38 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51170478 |
39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.45314693 |
40 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45149830 |
41 | MYC_22102868_ChIP-Seq_BL_Human | 1.42504916 |
42 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.40236621 |
43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40228958 |
44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.38403490 |
45 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37851030 |
46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37644086 |
47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.35113902 |
48 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32542459 |
49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.31891809 |
50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.28321320 |
51 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.28157576 |
52 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.26538388 |
53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24785422 |
54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21254542 |
55 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20294624 |
56 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20113161 |
57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19933072 |
58 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.19483230 |
59 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.18734610 |
60 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18717152 |
61 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18052348 |
62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18048989 |
63 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17417742 |
64 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17283553 |
65 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16858061 |
66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16419252 |
67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.16324682 |
68 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.14299492 |
69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14206028 |
70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12754767 |
71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11906847 |
72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11822344 |
73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10373384 |
74 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10289464 |
75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09809173 |
76 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09425313 |
77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08845574 |
78 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.08203846 |
79 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07552523 |
80 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07306901 |
81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06932172 |
82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05425841 |
83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04484696 |
84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04186516 |
85 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03979853 |
86 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02451911 |
87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01822740 |
88 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00813699 |
89 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00484014 |
90 | * MAF_26560356_Chip-Seq_TH1_Human | 0.99472568 |
91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99374474 |
92 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.99357713 |
93 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95436140 |
94 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.95270578 |
95 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93542877 |
96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93376816 |
97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93164001 |
98 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92968169 |
99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.91295633 |
100 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90681152 |
101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90646227 |
102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90117389 |
103 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89873232 |
104 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89088339 |
105 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.88737565 |
106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88695915 |
107 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88694648 |
108 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.88301312 |
109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.87758686 |
110 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.87697699 |
111 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86254052 |
112 | * MAF_26560356_Chip-Seq_TH2_Human | 0.85983788 |
113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.85900010 |
114 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.84859414 |
115 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.84327511 |
116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84281333 |
117 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.83907311 |
118 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.83617869 |
119 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.83448244 |
120 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83323343 |
121 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.82991359 |
122 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82223038 |
123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82189833 |
124 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81776020 |
125 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81728577 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.17189066 |
2 | MP0005360_urolithiasis | 5.14089581 |
3 | MP0005365_abnormal_bile_salt | 4.01401394 |
4 | MP0003806_abnormal_nucleotide_metabolis | 3.99912133 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.85434443 |
6 | MP0002877_abnormal_melanocyte_morpholog | 3.10038113 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.04777807 |
8 | MP0010329_abnormal_lipoprotein_level | 2.53035996 |
9 | MP0009840_abnormal_foam_cell | 2.51971602 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.47969564 |
11 | MP0003693_abnormal_embryo_hatching | 2.26136671 |
12 | MP0003252_abnormal_bile_duct | 2.21547125 |
13 | MP0003186_abnormal_redox_activity | 2.08822551 |
14 | MP0003786_premature_aging | 2.01222807 |
15 | MP0005332_abnormal_amino_acid | 1.88612942 |
16 | MP0000609_abnormal_liver_physiology | 1.80773875 |
17 | MP0004808_abnormal_hematopoietic_stem | 1.77978606 |
18 | MP0001666_abnormal_nutrient_absorption | 1.77714384 |
19 | MP0004957_abnormal_blastocyst_morpholog | 1.74387741 |
20 | MP0003705_abnormal_hypodermis_morpholog | 1.65999065 |
21 | MP0010234_abnormal_vibrissa_follicle | 1.65499690 |
22 | MP0010094_abnormal_chromosome_stability | 1.64908558 |
23 | MP0005319_abnormal_enzyme/_coenzyme | 1.62426089 |
24 | MP0002009_preneoplasia | 1.62176445 |
25 | MP0003111_abnormal_nucleus_morphology | 1.62175837 |
26 | MP0005083_abnormal_biliary_tract | 1.59962355 |
27 | MP0001764_abnormal_homeostasis | 1.57408471 |
28 | MP0001661_extended_life_span | 1.54227885 |
29 | MP0002166_altered_tumor_susceptibility | 1.51422933 |
30 | MP0010352_gastrointestinal_tract_polyps | 1.50872461 |
31 | MP0005058_abnormal_lysosome_morphology | 1.49332824 |
32 | MP0005670_abnormal_white_adipose | 1.48778282 |
33 | MP0008057_abnormal_DNA_replication | 1.48244582 |
34 | MP0004019_abnormal_vitamin_homeostasis | 1.44182562 |
35 | MP0003077_abnormal_cell_cycle | 1.41732689 |
36 | MP0002080_prenatal_lethality | 1.41259996 |
37 | MP0001853_heart_inflammation | 1.39131353 |
38 | MP0003763_abnormal_thymus_physiology | 1.37224097 |
39 | MP0002118_abnormal_lipid_homeostasis | 1.34452668 |
40 | MP0002396_abnormal_hematopoietic_system | 1.33035667 |
41 | MP0001697_abnormal_embryo_size | 1.32876105 |
42 | MP0003195_calcinosis | 1.31322054 |
43 | MP0005076_abnormal_cell_differentiation | 1.30421020 |
44 | MP0000598_abnormal_liver_morphology | 1.29186228 |
45 | MP0000678_abnormal_parathyroid_gland | 1.26778724 |
46 | MP0000358_abnormal_cell_content/ | 1.24762624 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 1.21594205 |
48 | MP0000703_abnormal_thymus_morphology | 1.19380304 |
49 | MP0002138_abnormal_hepatobiliary_system | 1.19248526 |
50 | MP0009643_abnormal_urine_homeostasis | 1.19010533 |
51 | MP0004233_abnormal_muscle_weight | 1.18841421 |
52 | MP0002006_tumorigenesis | 1.16469198 |
53 | MP0003436_decreased_susceptibility_to | 1.15583107 |
54 | MP0002132_abnormal_respiratory_system | 1.14305250 |
55 | MP0006036_abnormal_mitochondrial_physio | 1.11841443 |
56 | MP0002086_abnormal_extraembryonic_tissu | 1.07674702 |
57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05729881 |
58 | MP0005501_abnormal_skin_physiology | 1.05069143 |
59 | MP0009697_abnormal_copulation | 1.04025190 |
60 | MP0000490_abnormal_crypts_of | 1.03971430 |
61 | MP0009763_increased_sensitivity_to | 1.03648917 |
62 | MP0008469_abnormal_protein_level | 1.03462576 |
63 | MP0001835_abnormal_antigen_presentation | 1.02156091 |
64 | MP0009278_abnormal_bone_marrow | 0.99831344 |
65 | MP0003718_maternal_effect | 0.99805631 |
66 | MP0001881_abnormal_mammary_gland | 0.99657217 |
67 | MP0004782_abnormal_surfactant_physiolog | 0.98159296 |
68 | MP0005397_hematopoietic_system_phenotyp | 0.96176153 |
69 | MP0001545_abnormal_hematopoietic_system | 0.96176153 |
70 | MP0009053_abnormal_anal_canal | 0.95728563 |
71 | MP0000685_abnormal_immune_system | 0.95408060 |
72 | MP0001730_embryonic_growth_arrest | 0.94747103 |
73 | MP0008058_abnormal_DNA_repair | 0.94608878 |
74 | MP0008007_abnormal_cellular_replicative | 0.94231544 |
75 | MP0005451_abnormal_body_composition | 0.92310990 |
76 | MP0005464_abnormal_platelet_physiology | 0.91799021 |
77 | MP0010307_abnormal_tumor_latency | 0.91622401 |
78 | MP0005621_abnormal_cell_physiology | 0.90736731 |
79 | MP0005666_abnormal_adipose_tissue | 0.90317977 |
80 | MP0005384_cellular_phenotype | 0.89302712 |
81 | MP0009785_altered_susceptibility_to | 0.88829002 |
82 | MP0003315_abnormal_perineum_morphology | 0.87471414 |
83 | MP0005647_abnormal_sex_gland | 0.86665438 |
84 | MP0000003_abnormal_adipose_tissue | 0.85855514 |
85 | MP0002796_impaired_skin_barrier | 0.84270334 |
86 | MP0002019_abnormal_tumor_incidence | 0.84016439 |
87 | MP0009379_abnormal_foot_pigmentation | 0.83535029 |
88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83101382 |
89 | MP0008995_early_reproductive_senescence | 0.81726385 |
90 | MP0001873_stomach_inflammation | 0.81698529 |
91 | MP0005266_abnormal_metabolism | 0.81504948 |
92 | MP0001727_abnormal_embryo_implantation | 0.80478186 |
93 | MP0005025_abnormal_response_to | 0.80438951 |
94 | MP0009333_abnormal_splenocyte_physiolog | 0.79866796 |
95 | MP0004147_increased_porphyrin_level | 0.79401298 |
96 | MP0004264_abnormal_extraembryonic_tissu | 0.79336283 |
97 | MP0002060_abnormal_skin_morphology | 0.79224727 |
98 | MP0005023_abnormal_wound_healing | 0.79138317 |
99 | MP0002970_abnormal_white_adipose | 0.78888222 |
100 | MP0005408_hypopigmentation | 0.78869627 |
101 | MP0008260_abnormal_autophagy | 0.78805465 |
102 | MP0002971_abnormal_brown_adipose | 0.78615935 |
103 | MP0005330_cardiomyopathy | 0.76758221 |
104 | MP0000350_abnormal_cell_proliferation | 0.76570154 |
105 | MP0000689_abnormal_spleen_morphology | 0.76508413 |
106 | MP0005375_adipose_tissue_phenotype | 0.75935266 |
107 | MP0009931_abnormal_skin_appearance | 0.73868220 |
108 | MP0003868_abnormal_feces_composition | 0.73776863 |
109 | MP0001845_abnormal_inflammatory_respons | 0.73319564 |
110 | MP0002085_abnormal_embryonic_tissue | 0.73237528 |
111 | MP0005376_homeostasis/metabolism_phenot | 0.73148993 |
112 | MP0009765_abnormal_xenobiotic_induced | 0.72428042 |
113 | MP0002254_reproductive_system_inflammat | 0.72383032 |
114 | MP0003566_abnormal_cell_adhesion | 0.72360560 |
115 | MP0009764_decreased_sensitivity_to | 0.72133834 |
116 | MP0010155_abnormal_intestine_physiology | 0.72094060 |
117 | MP0003724_increased_susceptibility_to | 0.71208548 |
118 | MP0000858_altered_metastatic_potential | 0.70283447 |
119 | MP0005636_abnormal_mineral_homeostasis | 0.70049622 |
120 | MP0009115_abnormal_fat_cell | 0.69935039 |
121 | MP0000716_abnormal_immune_system | 0.69590819 |
122 | MP0002084_abnormal_developmental_patter | 0.69518196 |
123 | MP0001216_abnormal_epidermal_layer | 0.69517521 |
124 | MP0001800_abnormal_humoral_immune | 0.69349997 |
125 | MP0002722_abnormal_immune_system | 0.69154401 |
126 | MP0005220_abnormal_exocrine_pancreas | 0.68599785 |
127 | MP0008932_abnormal_embryonic_tissue | 0.68306127 |
128 | MP0003011_delayed_dark_adaptation | 0.67697879 |
129 | MP0006054_spinal_hemorrhage | 0.65919076 |
130 | MP0004185_abnormal_adipocyte_glucose | 0.65904671 |
131 | MP0008873_increased_physiological_sensi | 0.65606359 |
132 | MP0005075_abnormal_melanosome_morpholog | 0.65023172 |
133 | MP0009642_abnormal_blood_homeostasis | 0.64697485 |
134 | MP0001672_abnormal_embryogenesis/_devel | 0.64301676 |
135 | MP0005380_embryogenesis_phenotype | 0.64301676 |
136 | MP0002136_abnormal_kidney_physiology | 0.64181582 |
137 | MP0006035_abnormal_mitochondrial_morpho | 0.62355627 |
138 | MP0005334_abnormal_fat_pad | 0.62138004 |
139 | MP0009672_abnormal_birth_weight | 0.62078059 |
140 | MP0002419_abnormal_innate_immunity | 0.61727986 |
141 | MP0002398_abnormal_bone_marrow | 0.61663507 |
142 | MP0002088_abnormal_embryonic_growth/wei | 0.61439908 |
143 | MP0002429_abnormal_blood_cell | 0.61034696 |
144 | MP0003984_embryonic_growth_retardation | 0.60872373 |
145 | MP0000313_abnormal_cell_death | 0.60792224 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.01394729 |
2 | Hypobetalipoproteinemia (HP:0003563) | 4.89163801 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.76126352 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.66816102 |
5 | Deep venous thrombosis (HP:0002625) | 4.43039003 |
6 | Xanthomatosis (HP:0000991) | 4.42578639 |
7 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.11597645 |
8 | Hyperglycinuria (HP:0003108) | 4.09059220 |
9 | Hyperammonemia (HP:0001987) | 3.98578444 |
10 | Abnormal gallbladder physiology (HP:0012438) | 3.85495499 |
11 | Cholecystitis (HP:0001082) | 3.85495499 |
12 | Microvesicular hepatic steatosis (HP:0001414) | 3.73326555 |
13 | Hyperlipoproteinemia (HP:0010980) | 3.69926793 |
14 | Abnormality of glycine metabolism (HP:0010895) | 3.63863013 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63863013 |
16 | Abnormality of glycolysis (HP:0004366) | 3.63048611 |
17 | Prolonged partial thromboplastin time (HP:0003645) | 3.62061446 |
18 | Hypolipoproteinemia (HP:0010981) | 3.61258555 |
19 | Progressive muscle weakness (HP:0003323) | 3.58071374 |
20 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.50793568 |
21 | Hypoglycemic coma (HP:0001325) | 3.50193299 |
22 | Chromsome breakage (HP:0040012) | 3.46471386 |
23 | Hyperglycinemia (HP:0002154) | 3.45020749 |
24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.44558214 |
25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.42794756 |
26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.42542230 |
27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.24021999 |
28 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.21891323 |
29 | Ragged-red muscle fibers (HP:0003200) | 3.21589697 |
30 | Complement deficiency (HP:0004431) | 3.20674400 |
31 | Increased serum pyruvate (HP:0003542) | 3.20457313 |
32 | Epidermoid cyst (HP:0200040) | 3.19401094 |
33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.16699115 |
34 | Abnormality of methionine metabolism (HP:0010901) | 3.11366561 |
35 | Joint hemorrhage (HP:0005261) | 3.04329460 |
36 | Nausea (HP:0002018) | 3.03948550 |
37 | Abnormality of the common coagulation pathway (HP:0010990) | 3.01271293 |
38 | Hypoalphalipoproteinemia (HP:0003233) | 2.95051335 |
39 | Ketosis (HP:0001946) | 2.92942771 |
40 | Hypercholesterolemia (HP:0003124) | 2.85112980 |
41 | Dicarboxylic aciduria (HP:0003215) | 2.83690265 |
42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.83690265 |
43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.82703158 |
44 | Abnormality of the intrinsic pathway (HP:0010989) | 2.75474338 |
45 | Fat malabsorption (HP:0002630) | 2.75196981 |
46 | Abnormality of complement system (HP:0005339) | 2.69197389 |
47 | Multiple enchondromatosis (HP:0005701) | 2.67064403 |
48 | Hyperbilirubinemia (HP:0002904) | 2.66863236 |
49 | Seborrheic dermatitis (HP:0001051) | 2.65286768 |
50 | Abnormality of serum amino acid levels (HP:0003112) | 2.63491478 |
51 | Hypertensive crisis (HP:0100735) | 2.62606560 |
52 | Orthostatic hypotension (HP:0001278) | 2.61594766 |
53 | Acute myeloid leukemia (HP:0004808) | 2.52614146 |
54 | Generalized aminoaciduria (HP:0002909) | 2.43162579 |
55 | Abnormal cartilage morphology (HP:0002763) | 2.42304458 |
56 | Pallor (HP:0000980) | 2.40675660 |
57 | Truncus arteriosus (HP:0001660) | 2.40123488 |
58 | Trismus (HP:0000211) | 2.39200834 |
59 | Fatigue (HP:0012378) | 2.38035865 |
60 | Myocardial infarction (HP:0001658) | 2.37088067 |
61 | Lethargy (HP:0001254) | 2.36680096 |
62 | Spastic diplegia (HP:0001264) | 2.35985402 |
63 | Oral leukoplakia (HP:0002745) | 2.34044693 |
64 | Hypertriglyceridemia (HP:0002155) | 2.32132172 |
65 | Progressive external ophthalmoplegia (HP:0000590) | 2.29477721 |
66 | Hepatocellular carcinoma (HP:0001402) | 2.29256749 |
67 | Overlapping toe (HP:0001845) | 2.27174469 |
68 | Myelodysplasia (HP:0002863) | 2.25754031 |
69 | Ankyloglossia (HP:0010296) | 2.23403255 |
70 | Abnormality of iron homeostasis (HP:0011031) | 2.23156301 |
71 | Abnormality of purine metabolism (HP:0004352) | 2.18255915 |
72 | Proximal tubulopathy (HP:0000114) | 2.17977813 |
73 | Squamous cell carcinoma (HP:0002860) | 2.17342685 |
74 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.17005330 |
75 | Delayed CNS myelination (HP:0002188) | 2.16872411 |
76 | Premature ovarian failure (HP:0008209) | 2.16557954 |
77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16474588 |
78 | Abnormality of the preputium (HP:0100587) | 2.15016880 |
79 | Metabolic acidosis (HP:0001942) | 2.14407083 |
80 | Rough bone trabeculation (HP:0100670) | 2.13517129 |
81 | Increased mean platelet volume (HP:0011877) | 2.10815135 |
82 | Reticulocytopenia (HP:0001896) | 2.08929007 |
83 | Cholelithiasis (HP:0001081) | 2.08142487 |
84 | Steatorrhea (HP:0002570) | 2.07757300 |
85 | Abnormal platelet volume (HP:0011876) | 2.07471662 |
86 | Type I transferrin isoform profile (HP:0003642) | 2.07285701 |
87 | Septate vagina (HP:0001153) | 2.06773110 |
88 | Abnormal number of erythroid precursors (HP:0012131) | 2.06647138 |
89 | Acanthocytosis (HP:0001927) | 2.06377328 |
90 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.05890974 |
91 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.05814658 |
92 | Poikilocytosis (HP:0004447) | 2.05143494 |
93 | Pancytopenia (HP:0001876) | 2.04932390 |
94 | Systemic lupus erythematosus (HP:0002725) | 2.04614456 |
95 | Pancreatitis (HP:0001733) | 2.03577470 |
96 | Gout (HP:0001997) | 2.02977795 |
97 | Thrombocytosis (HP:0001894) | 2.01856197 |
98 | Ketoacidosis (HP:0001993) | 2.01286090 |
99 | Cerebral edema (HP:0002181) | 1.98751083 |
100 | Recurrent viral infections (HP:0004429) | 1.96259056 |
101 | Renal cortical cysts (HP:0000803) | 1.94988060 |
102 | Abnormality of the tricuspid valve (HP:0001702) | 1.94949710 |
103 | Increased serum ferritin (HP:0003281) | 1.94602983 |
104 | Gingival bleeding (HP:0000225) | 1.94268361 |
105 | Rhabdomyolysis (HP:0003201) | 1.93717681 |
106 | Colitis (HP:0002583) | 1.93520923 |
107 | Hypergonadotropic hypogonadism (HP:0000815) | 1.93249266 |
108 | Secondary amenorrhea (HP:0000869) | 1.93210099 |
109 | Acute lymphatic leukemia (HP:0006721) | 1.90411753 |
110 | Hyperthyroidism (HP:0000836) | 1.89432718 |
111 | Aplastic anemia (HP:0001915) | 1.87994133 |
112 | Hypochromic microcytic anemia (HP:0004840) | 1.87911136 |
113 | Hydroxyprolinuria (HP:0003080) | 1.87852177 |
114 | Abnormality of proline metabolism (HP:0010907) | 1.87852177 |
115 | Cutaneous melanoma (HP:0012056) | 1.86882713 |
116 | Malnutrition (HP:0004395) | 1.85823699 |
117 | Nonimmune hydrops fetalis (HP:0001790) | 1.85631564 |
118 | Abnormality of reticulocytes (HP:0004312) | 1.85484412 |
119 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.83744756 |
120 | Opisthotonus (HP:0002179) | 1.83048057 |
121 | Thrombophlebitis (HP:0004418) | 1.81309643 |
122 | Esophageal varix (HP:0002040) | 1.79611202 |
123 | Agammaglobulinemia (HP:0004432) | 1.79502828 |
124 | Megaloblastic anemia (HP:0001889) | 1.78929737 |
125 | Hypoparathyroidism (HP:0000829) | 1.78787282 |
126 | Myoglobinuria (HP:0002913) | 1.78152541 |
127 | Reduced antithrombin III activity (HP:0001976) | 1.78134852 |
128 | Polycythemia (HP:0001901) | 1.77832599 |
129 | Late onset (HP:0003584) | 1.77609062 |
130 | Hepatosplenomegaly (HP:0001433) | 1.76855674 |
131 | Abnormality of oral frenula (HP:0000190) | 1.76812243 |
132 | Ileus (HP:0002595) | 1.76643692 |
133 | Vomiting (HP:0002013) | 1.76216774 |
134 | Increased muscle lipid content (HP:0009058) | 1.75853644 |
135 | Ureteral duplication (HP:0000073) | 1.75791382 |
136 | Deviation of the thumb (HP:0009603) | 1.75704163 |
137 | Abnormal gallbladder morphology (HP:0012437) | 1.74909652 |
138 | Neoplasm of head and neck (HP:0012288) | 1.74413884 |
139 | Esophageal neoplasm (HP:0100751) | 1.74413884 |
140 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73636997 |
141 | Villous atrophy (HP:0011473) | 1.73636997 |
142 | Abnormality of urine glucose concentration (HP:0011016) | 1.72959699 |
143 | Glycosuria (HP:0003076) | 1.72959699 |
144 | Brushfield spots (HP:0001088) | 1.72872830 |
145 | Increased intramyocellular lipid droplets (HP:0012240) | 1.72847986 |
146 | Vertebral compression fractures (HP:0002953) | 1.72772851 |
147 | Reticulocytosis (HP:0001923) | 1.72296827 |
148 | Petechiae (HP:0000967) | 1.72125656 |
149 | Entropion (HP:0000621) | 1.70825201 |
150 | Hyperacusis (HP:0010780) | 1.70722256 |
151 | Proximal placement of thumb (HP:0009623) | 1.70670524 |
152 | Increased nuchal translucency (HP:0010880) | 1.70608949 |
153 | Macrocytic anemia (HP:0001972) | 1.70005178 |
154 | Progressive hearing impairment (HP:0001730) | 1.69910880 |
155 | Birth length less than 3rd percentile (HP:0003561) | 1.69483581 |
156 | Increased serum lactate (HP:0002151) | 1.69052586 |
157 | Elevated hepatic transaminases (HP:0002910) | 1.68830420 |
158 | Conjugated hyperbilirubinemia (HP:0002908) | 1.68684144 |
159 | Hepatic necrosis (HP:0002605) | 1.68171546 |
160 | Abnormality of the anterior horn cell (HP:0006802) | 1.67421975 |
161 | Degeneration of anterior horn cells (HP:0002398) | 1.67421975 |
162 | Selective tooth agenesis (HP:0001592) | 1.66518900 |
163 | Menorrhagia (HP:0000132) | 1.66088033 |
164 | Impaired proprioception (HP:0010831) | 1.65867073 |
165 | Abnormal platelet function (HP:0011869) | 1.65751528 |
166 | Impaired platelet aggregation (HP:0003540) | 1.65751528 |
167 | Skin nodule (HP:0200036) | 1.65321804 |
168 | Abnormality of the umbilical cord (HP:0010881) | 1.64094015 |
169 | Exercise intolerance (HP:0003546) | 1.61501753 |
170 | Abnormality of the gallbladder (HP:0005264) | 1.61194611 |
171 | Sparse lateral eyebrow (HP:0005338) | 1.60934886 |
172 | Spastic paraparesis (HP:0002313) | 1.60787427 |
173 | Insomnia (HP:0100785) | 1.60072291 |
174 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.59265297 |
175 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59265297 |
176 | Abnormal protein glycosylation (HP:0012346) | 1.59265297 |
177 | Abnormal glycosylation (HP:0012345) | 1.59265297 |
178 | Deep philtrum (HP:0002002) | 1.59108442 |
179 | Abnormal trabecular bone morphology (HP:0100671) | 1.59089981 |
180 | IgM deficiency (HP:0002850) | 1.58587147 |
181 | Achilles tendon contracture (HP:0001771) | 1.58582637 |
182 | Cellulitis (HP:0100658) | 1.58511492 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 3.54919758 |
2 | EIF2AK1 | 2.73222996 |
3 | WEE1 | 2.58931487 |
4 | SMG1 | 2.55071070 |
5 | BUB1 | 2.48262616 |
6 | VRK2 | 2.35513820 |
7 | ERN1 | 2.28974389 |
8 | CDC7 | 2.24949701 |
9 | PKN2 | 2.10996971 |
10 | NME2 | 1.90287462 |
11 | TRIB3 | 1.86856737 |
12 | FLT3 | 1.84590527 |
13 | PRPF4B | 1.71804611 |
14 | NEK2 | 1.68043398 |
15 | NEK1 | 1.67653161 |
16 | PDK2 | 1.65638640 |
17 | ICK | 1.60804225 |
18 | TAOK3 | 1.60302349 |
19 | EEF2K | 1.59502846 |
20 | TTK | 1.58467917 |
21 | MAP2K3 | 1.57561372 |
22 | SIK1 | 1.56698941 |
23 | MAP3K10 | 1.55928332 |
24 | PIM2 | 1.51769771 |
25 | MAP4K1 | 1.49946382 |
26 | RPS6KB2 | 1.49027262 |
27 | PLK4 | 1.46859673 |
28 | CDK4 | 1.43997684 |
29 | STK10 | 1.42314987 |
30 | TESK2 | 1.42085676 |
31 | MST1R | 1.40365816 |
32 | FGFR4 | 1.37888086 |
33 | MAP3K8 | 1.34964893 |
34 | KDR | 1.34468927 |
35 | RIPK4 | 1.31992608 |
36 | TYK2 | 1.31509336 |
37 | CDK7 | 1.29965311 |
38 | RPS6KA4 | 1.29177877 |
39 | CLK1 | 1.29085338 |
40 | ACVR1B | 1.27491466 |
41 | BRSK2 | 1.26766602 |
42 | EPHA2 | 1.26415453 |
43 | MAP3K11 | 1.25948192 |
44 | PIM1 | 1.18975519 |
45 | NME1 | 1.18033857 |
46 | EIF2AK3 | 1.17805183 |
47 | LRRK2 | 1.14615748 |
48 | IRAK3 | 1.14026673 |
49 | TBK1 | 1.13328977 |
50 | AURKB | 1.13310572 |
51 | CDK8 | 1.13071980 |
52 | CDK6 | 1.10866764 |
53 | SRPK1 | 1.10503321 |
54 | IKBKB | 1.10095079 |
55 | PASK | 1.09468375 |
56 | PLK1 | 1.07392558 |
57 | ATR | 1.07030339 |
58 | STK4 | 1.04336706 |
59 | NEK9 | 1.02720160 |
60 | GRK6 | 1.01004571 |
61 | MAPKAPK3 | 1.00206584 |
62 | MAPK11 | 0.99635061 |
63 | IRAK4 | 0.97818389 |
64 | KSR2 | 0.97579525 |
65 | STK16 | 0.96966016 |
66 | CCNB1 | 0.96741282 |
67 | MAP3K13 | 0.95369371 |
68 | SCYL2 | 0.95198747 |
69 | TGFBR1 | 0.95187254 |
70 | PAK4 | 0.94839186 |
71 | MAP3K3 | 0.94009647 |
72 | MAP3K14 | 0.92957755 |
73 | ABL2 | 0.91100350 |
74 | RAF1 | 0.88828533 |
75 | TESK1 | 0.85470198 |
76 | BLK | 0.84375154 |
77 | PTK6 | 0.83492632 |
78 | JAK3 | 0.83340007 |
79 | BTK | 0.81801048 |
80 | PBK | 0.81111904 |
81 | BRSK1 | 0.79278006 |
82 | ALK | 0.79155776 |
83 | EIF2AK2 | 0.78080067 |
84 | MKNK1 | 0.77111666 |
85 | TSSK6 | 0.76382160 |
86 | DYRK3 | 0.74493784 |
87 | CDK12 | 0.72830728 |
88 | BRD4 | 0.72526509 |
89 | CSF1R | 0.71869116 |
90 | BMPR2 | 0.68067233 |
91 | ARAF | 0.65581391 |
92 | TLK1 | 0.65453238 |
93 | CDK2 | 0.64740760 |
94 | AURKA | 0.64575276 |
95 | ZAK | 0.63183051 |
96 | CHUK | 0.63045647 |
97 | TEC | 0.62004561 |
98 | CHEK1 | 0.61619066 |
99 | ZAP70 | 0.61589838 |
100 | ERBB4 | 0.60979362 |
101 | BRAF | 0.60455421 |
102 | KIT | 0.58970165 |
103 | VRK1 | 0.58282660 |
104 | IKBKE | 0.56624798 |
105 | CSNK2A1 | 0.56377144 |
106 | CHEK2 | 0.56267259 |
107 | PIK3CG | 0.55789514 |
108 | CDK1 | 0.55774974 |
109 | MST4 | 0.55758103 |
110 | STK3 | 0.53982931 |
111 | DAPK1 | 0.52004816 |
112 | MAPKAPK5 | 0.51199002 |
113 | PLK3 | 0.51191392 |
114 | JAK2 | 0.50725105 |
115 | CSNK2A2 | 0.50681345 |
116 | ILK | 0.50601674 |
117 | MTOR | 0.48353244 |
118 | TAOK2 | 0.46602733 |
119 | RPS6KA5 | 0.44215850 |
120 | CDK9 | 0.43118129 |
121 | MAP2K2 | 0.42930414 |
122 | STK38L | 0.42791727 |
123 | PAK1 | 0.41263131 |
124 | MAPK4 | 0.41178953 |
125 | ATM | 0.40540704 |
126 | MAP3K2 | 0.39564657 |
127 | PDK3 | 0.39337309 |
128 | PDK4 | 0.39337309 |
129 | DYRK1B | 0.38239225 |
130 | AKT2 | 0.37387757 |
131 | TRPM7 | 0.35711935 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.80744043 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.65292405 |
3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.35610078 |
4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.24540891 |
5 | DNA replication_Homo sapiens_hsa03030 | 2.23185013 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.19732391 |
7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19380371 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.15424280 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09204787 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06587265 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.99603438 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.98971689 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.95153349 |
14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.90569676 |
15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.80009116 |
16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77088622 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75197771 |
18 | Mismatch repair_Homo sapiens_hsa03430 | 1.71973415 |
19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.66146867 |
20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66027191 |
21 | Peroxisome_Homo sapiens_hsa04146 | 1.65260542 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62951619 |
23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59515907 |
24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57810945 |
25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55233764 |
26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.54292361 |
27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.52693757 |
28 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47973296 |
29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.47084588 |
30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.46301812 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44780163 |
32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44112907 |
33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40601272 |
34 | Ribosome_Homo sapiens_hsa03010 | 1.40582183 |
35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40461262 |
36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36050739 |
37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34791293 |
38 | Proteasome_Homo sapiens_hsa03050 | 1.33274400 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32568697 |
40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31777269 |
41 | Base excision repair_Homo sapiens_hsa03410 | 1.31713411 |
42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.31048493 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30812606 |
44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25411970 |
45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25297478 |
46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25223771 |
47 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.21977753 |
48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20752360 |
49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19601860 |
50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.18018466 |
51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17689520 |
52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16099405 |
53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15215052 |
54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.12195933 |
55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12112387 |
56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.10321590 |
57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04653594 |
58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03460650 |
59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.02160380 |
60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02131614 |
61 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.00698611 |
62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00424346 |
63 | Homologous recombination_Homo sapiens_hsa03440 | 0.98927470 |
64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97099577 |
65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96207291 |
66 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93145752 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92178133 |
68 | RNA transport_Homo sapiens_hsa03013 | 0.90706728 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89536753 |
70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89035759 |
71 | Spliceosome_Homo sapiens_hsa03040 | 0.87735443 |
72 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86761498 |
73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86392820 |
74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83569119 |
75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81911719 |
76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80630132 |
77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78479221 |
78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77964108 |
79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77884260 |
80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75483999 |
81 | RNA polymerase_Homo sapiens_hsa03020 | 0.74190616 |
82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74136001 |
83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72414938 |
84 | Lysine degradation_Homo sapiens_hsa00310 | 0.71557118 |
85 | Bladder cancer_Homo sapiens_hsa05219 | 0.71230624 |
86 | ABC transporters_Homo sapiens_hsa02010 | 0.69894695 |
87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67965428 |
88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67346830 |
89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64971698 |
90 | Bile secretion_Homo sapiens_hsa04976 | 0.63750862 |
91 | Cell cycle_Homo sapiens_hsa04110 | 0.63733641 |
92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56461263 |
93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53515433 |
94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53481273 |
95 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.53347749 |
96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52096464 |
97 | Shigellosis_Homo sapiens_hsa05131 | 0.50909432 |
98 | Legionellosis_Homo sapiens_hsa05134 | 0.50294550 |
99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50171147 |
100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48132201 |
101 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47999733 |
102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47542118 |
103 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46851849 |
104 | Hepatitis B_Homo sapiens_hsa05161 | 0.46066154 |
105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45636420 |
106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43320364 |
107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43239358 |
108 | Protein export_Homo sapiens_hsa03060 | 0.42973224 |
109 | Apoptosis_Homo sapiens_hsa04210 | 0.42613505 |
110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42143708 |
111 | RNA degradation_Homo sapiens_hsa03018 | 0.41278669 |
112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.41020518 |
113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37970613 |
114 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35430129 |
115 | Influenza A_Homo sapiens_hsa05164 | 0.33189205 |
116 | Measles_Homo sapiens_hsa05162 | 0.32683251 |
117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31802194 |
118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31212660 |
119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29934135 |
120 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28800375 |
121 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28434583 |
122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27611295 |
123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.27295180 |
124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27107326 |
125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26268566 |
126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24133744 |
127 | * Purine metabolism_Homo sapiens_hsa00230 | 0.22576604 |
128 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.22476926 |
129 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.21448275 |
130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20590146 |
131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20309055 |
132 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18943825 |
133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18119092 |